uniQure：亨廷顿病取得突破，市场大得不容忽视
· seekingalpha.com
分析师认为uniQure（QURE）的AMT-130是一种潜在亨廷顿病疗法：高剂量治疗在3年内使cUHDRS下降减缓80%。
Editor's note: Seeking Alpha is proud to welcome Biotech Fundamentals as a new contributing analyst. You can become one too! Share your best investment idea by ...